PLANEGG, Germany– Using Biomax Informatics’ NeuroXM knowledge management platform, scientists from the Universities of Nottingham, Newcastle, Qingdao, Shanghai and Munich have studied the change in the connectome in drug-resistant epilepsy patients. They discovered that connectivity between and within brain regions can be a precise predictor for disease progression and epilepsy surgery outcome.
The NeuroXM Brain Science Suite of Biomax was used to develop a knowledge model for high-resolution intra-areal connectivity with more than 50,000 cortical nodes and several million connections, as well as corresponding automated processing pipelines. This connectivity network could then be visualized and accessed via the web portal of NICARA™, the neuroimaging solution offered by Biomax. “Our experience shows us that our software can be easily deployed in hospitals,” explained project leader Dr. Markus Butz-Ostendorf of Biomax. “In addition, it can also be combined with other data from genetics or from other imaging approaches such as PET, CT or EEG.”
Dr. Marcus Kaiser, Professor of Neuroinformatics at the University of Nottingham, confirms, “The use of NeuroXM and NICARA is central to this research project. With the help of this advanced neuroimaging solution, we can analyze and evaluate the changes in the local network within brain regions and thus assess whether surgery will be successful or not.”
The results from this study have now been published in the journal Human Brain Mapping.
